Search results
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 22 hours agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Rating of “Moderate Buy” by Analysts
ETF DAILY NEWS· 1 day agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen brokerages that are covering the stock ...
Rigel Pharmaceuticals’ (RIGL) “Buy” Rating Reiterated at HC Wainwright
ETF DAILY NEWS· 1 day agoRigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a report released on Monday, Benzinga reports ...
American Trust Sells 187 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
ETF DAILY NEWS· 1 day agoAmerican Trust lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 10.3% in the 4th quarter, according to the company in its most recent filing ...
Microrobots made of algae carry chemo directly to lung tumors, improving cancer treatment
The Conversation via Yahoo News· 6 days agoMicroalgae can swim through your body. CSIRO/Wikimedia Commons, CC BY...produce. Our biohybrid...
Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Sees Large Increase in Short Interest
ETF DAILY NEWS· 2 days agoAlgernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short ...
Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 11 Best Feminist Stocks To Invest In. In this article, we are...
Regeneron holds Buy rating and price target from TD Cowen By Investing.com
Investing.com· 4 days agoOn Friday, TD (TSX:TD) Cowen maintained a Buy rating on shares of Regeneron (NASDAQ:REGN) ...
Gateway - Quartz
Quartz· 2 hours agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer Eyebiotech (EyeBio) as the company tries to diversify beyond its best-selling cancer drug Keytruda ...
Johnson & Johnson lawsuit ends with $14 million for Colorado
KKCO Grand Junction CO· 5 days agoAttorney General Phil Weiser, alongside 42 other state attorneys general, have secured a $700...
